Literature DB >> 3461283

MHC antigens and malignancy.

H Festenstein, F Garrido.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3461283     DOI: 10.1038/322502a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  26 in total

Review 1.  Application of molecular cytogenetic techniques to the evaluation of renal parenchymal tumors.

Authors:  G Kovacs
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

2.  Identification of a cis-acting element in the class I major histocompatibility complex gene promoter responsive to activation by retroviral sequences.

Authors:  S Y Choi; K van de Mark; D V Faller
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

3.  Murine retroviruses control class I major histocompatibility antigen gene expression via a trans effect at the transcriptional level.

Authors:  L D Wilson; D C Flyer; D V Faller
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

4.  The expression of MHC antigens on cultured oral keratinocytes and relationship to malignancy.

Authors:  I J Crane; S Q Rice; J Luker; L de Gay; C Scully; S S Prime
Journal:  Br J Exp Pathol       Date:  1988-10

5.  Correlation between classification of human urothelial cell lines and HLA-A,B,C expression.

Authors:  S S Ottesen; V Tromholt; J Kieler
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

6.  Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1.

Authors:  S K Ghosh; D V Faller
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

7.  HLA-DR expression is associated with excellent prognosis in squamous cell carcinoma of the larynx.

Authors:  F Esteban; F Ruiz-Cabello; A Concha; M Pérez-Ayala; J A Sánchez-Rozas; F Garrido
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

8.  Human hepatoma cells expressing MHC antigens display accessory cell function: dependence on LFA-1/ICAM-1 interaction.

Authors:  M Paroli; G Carloni; A Franco; G De Petrillo; E Alfani; A Perrone; V Barnaba
Journal:  Immunology       Date:  1994-06       Impact factor: 7.397

9.  Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy.

Authors:  Rafael Carretero; José M Romero; Francisco Ruiz-Cabello; Isabel Maleno; Felix Rodriguez; Francisco M Camacho; Luis M Real; Federico Garrido; Teresa Cabrera
Journal:  Immunogenetics       Date:  2008-06-11       Impact factor: 2.846

10.  Phenotypic expression of histocompatibility antigens in human primary tumours and metastases.

Authors:  F Ruiz-Cabello; M A Lopez Nevot; J Gutierrez; M R Oliva; C Romero; A Ferron; F Esteban; C Huelin; M A Piris; C Rivas
Journal:  Clin Exp Metastasis       Date:  1989 Mar-Apr       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.